Author Interviews, Cancer Research, Lancet / 28.11.2014
Cancer Survival Varies Widely By Country and Cancer Type
MedicalResearch.com Interview with:
Dr Claudia Allemani PhD FHEA MFPH
Senior Lecturer in Cancer Epidemiology
Cancer Research UK Cancer Survival Group
Department of Non-Communicable Disease Epidemiology
London School of Hygiene and Tropical Medicine, London UK
Medical Research: What is the background for this study?
Dr. Allemani: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control.
The first CONCORD study was published in 2008.1 It brought together data from 101 cancer registries in 31 countries, and included 1.9 million patients diagnosed during 1990-94 with a cancer of the colon, rectum, breast or prostate and followed up to the end of 1999. It revealed very wide international differences in five-year survival, and it confirmed the well-known racial discrepancy in cancer survival in the USA.
CONCORD-2 is the most comprehensive international comparison of trends in population-based cancer patient survival to date. It extends the first study in three ways:
- it covers 10 common cancers: collectively, these account for almost two-thirds (63%) of all cancer patients diagnosed each year in both developed and developing countries
- it includes data on more than 25 million cancer patients, provided by 279 cancer registries in 67 countries, in 40 of which the data provide complete (100%) coverage of the national population
- it examines trends in cancer survival for patients diagnosed over the 15-year period 1995-2009 (more…)